Effect of prenatal multiple micronutrient supplementation vs iron and folic acid supplementation on size at birth and subsequent growth through 24 months of age: a systematic review and meta-analysis
Document Type
Journal Article
Publication Date
4-28-2025
Journal
The American journal of clinical nutrition
DOI
10.1016/j.ajcnut.2025.04.022
Keywords
birth size; infant growth; length; micronutrient supplements; pregnancy
Abstract
BACKGROUND: Prenatal multiple micronutrient supplements (MMS), in comparison to iron and folic acid (IFA) supplements, improve pregnancy outcomes, but less is known about their effect on infant growth. OBJECTIVE: We conducted a systematic review of trials comparing maternal MMS to IFA and assessed the effect on infants' anthropometric outcomes at birth, three, six, 12, 18, and 24 months of age. METHODS: We included trials from a Cochrane review and new studies identified through systematic literature searches in three databases. We calculated the pooled effect estimates with 95% confidence intervals (CI) using a generic inverse variance method, with fixed (primary analysis) and random effects, and assessed subgroup differences. RESULTS: The 19 included trials showed that MMS, compared to IFA, led to significantly greater: length and weight from birth to six months, head circumference (HC) from birth to 12 months, and mid-upper arm circumference (MUAC) through three months. Infants born to pregnant women taking MMS were longer at birth (mean difference: 0.05 cm (95% CI 0.02, 0.08)), and had higher length-for-age Z-score at birth (0.09 (0.06, 0.12)), three (0.09, (0.06, 0.12)) and six-months (0.04, (0.01, 0.07)) of age, but not thereafter. MMS resulted in significantly higher weight-for-age Z-score and HC-for-age Z-score until six months, and higher weight-for-length Z-score and MUAC-for-age- Z-score until three months. MMS reduced the risk of stunting (Risk Ratio (RR) 0.86, 95% CI 0.82-0.91), underweight (0.86 (0.81- 0.90)), small HC (0.84 (0.79, 0.90)), and low MUAC (0.90 (0.82, 0.99)) at three months, and wasting (0.90 (0.85, 0.96)) at birth. For some outcomes, effects were greater when MMS continued postpartum and in settings with higher prevalence of low birthweight. CONCLUSIONS: Prenatal MMS improved size at birth and subsequent infant growth through six months of age, but not thereafter. Results strengthen the evidence on MMS benefits beyond birth outcomes. PROSPERO REGISTRATION NUMBER: CRD42024551864.
APA Citation
Gomes, Filomena; Adu-Afarwuah, Seth; Agustina, Rina; Ali, Hasmot; Arcot, Amrita; Arifeen, Shams; Arnold, Charles D.; Black, Robert E.; Christian, Parul; Dewey, Kathryn G.; Fawzi, Wafaie; Hallamaa, Lotta; Hoddinott, John; Kissell, Mihaela C.; Kraemer, Klaus; Lachat, Carl; Moore, Sophie E.; Maleta, Kenneth; Pereira, Carolina; Roberfroid, Dominique; Shaikh, Saijuddin; Shankar, Anuraj H.; Smith, Emily R.; Subarkah; Sunawang; Wang, Dongqing; S-F Wu, Lee; and Mwangi, Martin N., "Effect of prenatal multiple micronutrient supplementation vs iron and folic acid supplementation on size at birth and subsequent growth through 24 months of age: a systematic review and meta-analysis" (2025). GW Authored Works. Paper 6974.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/6974
Department
Global Health